Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) and Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), announced today that it ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE